v3.26.1
Collaboration, License and Option Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 36 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2021
Aug. 01, 2026
May 14, 2026
Dec. 31, 2025
Nov. 18, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaboration Amendment Date             2019-04        
Liability to licensor $ 19,806       $ 19,806         $ 19,806  
BeiGene                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaboration Amendment Date             2021-11        
Upfront Non-Refundable Payment             $ 25,000        
Revenues   $ 0   $ 0 0 $ 0          
Current portion of deferred revenue                     $ 19,800
Liability to licensor 19,800       19,800         $ 19,800  
Context Therapeutics Inc                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Revenues 6,500   $ 0   6,500 $ 0          
Maximum Potential Aggregate Payments $ 133,500       $ 133,500            
Amended license agreement first payable amount                 $ 4,500,000    
Amended License Agreement Second Payable Amount               $ 2,000,000